Skip to main content
logo
Evotec SE (LON:0IRF)
London flag London · Delayed Price · Currency is GBP · Price in EUR
4.175
-0.160 (-3.69%)
At close: Mar 23, 2026

Revenue by Segment

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Discovery and Preclinical Development
611.55M672.98M702.02M--
Discovery and Preclinical Development Growth
-9.13%-4.14%---
Just - Evotec Biologics
186.62M108.45M49.43M--
Just - Evotec Biologics Growth
72.08%119.41%---
Intersegment Elimination
-1.21M---139.12M-115.78M
EVT Execute
---610.17M509.87M
EVT Execute Growth
---19.67%17.46%
EVT Innovate
---146.98M106.83M
EVT Innovate Growth
---37.58%12.37%
Total
796.97M781.43M751.45M618.03M500.92M
Total Growth
1.99%3.99%21.59%23.38%12.20%

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
USA
445.86M459.42M407.75M--
USA Growth
-2.95%12.67%---
Germany
32.90M34.13M58.90M--
Germany Growth
-3.60%-42.04%---
France
19.91M32.01M32.27M--
France Growth
-37.79%-0.83%---
United Kingdom
92.52M86.37M115.26M--
United Kingdom Growth
7.12%-25.06%---
Switzerland
109.04M64.92M22.00K--
Switzerland Growth
67.95%295009.09%---
Rest of the World
82.28M95.15M126.70M--
Rest of the World Growth
-13.53%-24.90%---
Unallocated
14.45M9.42M10.55M--
Unallocated Growth
53.45%-10.75%---
Total
796.97M781.43M751.45M--
Total Growth
1.99%3.99%---
Source: S&P Global Market Intelligence.